1-16 of 16
Authors: Tobias Goschzik
Journal Article
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies Get access
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2125–2139, https://doi.org/10.1093/neuonc/noae111
Published: 26 June 2024
Journal Article
NFS-03. MEDULLOBLASTOMA IN CHILDREN WITH FANCONI ANEMIA: ASSOCIATION WITH FA-D1/FA-N, SHH TYPE AND POOR SURVIVAL INDEPENDENT OF TREATMENT STRATEGIES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.561
Published: 18 June 2024
Journal Article
ETMR-11. RECURRENT GENETIC ALTERATIONS IN EPIGENETICALLY DEFINED PINEOBLASTOMA SUBTYPES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.181
Published: 18 June 2024
Journal Article
MDB-25. LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA REPRESENTS MORE THAN ONE DISEASE ENTITY
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i67, https://doi.org/10.1093/neuonc/noad073.257
Published: 12 June 2023
Journal Article
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups
Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1518–1529, https://doi.org/10.1093/neuonc/noad027
Published: 30 January 2023
Journal Article
MEDB-04. Young children with metastatic medulloblastoma: frequent requirement for radiotherapy in children with non-WNT/non-SHH medulloblastoma despite highly intensified chemotherapy – Results of the MET-HIT2000-BIS4 trial
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i104, https://doi.org/10.1093/neuonc/noac079.379
Published: 03 June 2022
Journal Article
RARE-12. Pineoblastoma of children and young adults in a national population: An analysis of the HIT-MED study cohort
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i11–i12, https://doi.org/10.1093/neuonc/noac079.037
Published: 03 June 2022
Journal Article
MEDB-35. Relationship between genetic profile, histology, clinical features and long-term outcome in young children medulloblastoma (YCMB) treated with upfront high dose chemotherapy (HDCT) in Italy
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i112–i113, https://doi.org/10.1093/neuonc/noac079.409
Published: 03 June 2022
Journal Article
MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i122, https://doi.org/10.1093/neuonc/noac079.442
Published: 03 June 2022
Journal Article
MEDB-61. Genetic alterations ofTP53 andOTX2 indicate increased risk of relapse in WNT medulloblastomas
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i120, https://doi.org/10.1093/neuonc/noac079.435
Published: 03 June 2022
Journal Article
EMBR-25. GENOME-WIDE GENETIC AND EPIGENETIC ASSESSMENT OF GROUP 4 MEDULLOBLASTOMA FOR IMPROVED, BIOMARKER DRIVEN, PROGNOSTICATION AND RISK-STRATIFICATION
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i11, https://doi.org/10.1093/neuonc/noab090.043
Published: 01 June 2021
Journal Article
PATH-32. GENOMIC LANDSCAPE AND BIOLOGY OF MEDULLOBLASTOMA IN ADULTS
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi150, https://doi.org/10.1093/neuonc/noz175.628
Published: 11 November 2019
Journal Article
MBCL-31. A WHOLE CHROMOSOME ABERRATION PHENOTYPE IN NON-WNT/NON-SHH TUMORS PREDICTS OUTCOME WITHIN STANDARD-RISK MEDULLOBLASTOMAS FROM THE HIT-SIOP-PNET4 CLINICAL TRIAL
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i123, https://doi.org/10.1093/neuonc/noy059.427
Published: 22 June 2018
Journal Article
MPTH-52. GENOMIC LANDSCAPE OF ADULT MEDULLOBLASTOMAS CLASSIFIED ACCORDING TO WHO 2016 GUIDELINES
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi117, https://doi.org/10.1093/neuonc/now212.486
Published: 07 November 2016
Journal Article
MB-46PROGNOSTIC RELEVANCE OF EPIGENETIC/BIOLOGICAL SUBGROUPS AND MYCC/MYCN GENE AMPLIFICATION IN A HOMOGENOUSLY TREATED METASTATIC MEDULLOBLASTOMA HIT2000 COHORT AGED 4-21 YEARS
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii107, https://doi.org/10.1093/neuonc/now076.44
Published: 30 May 2016
Journal Article
PROGNOSTIC SIGNIFICANCE OF CLINICAL, HISTOPATHOLOGICAL, AND MOLECULAR CHARACTERISTICS OF MEDULLOBLASTOMAS IN THE PROSPECTIVE HIT2000 MULTICENTER CLINICAL TRIAL COHORT Get access
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Pages iii24–iii25, https://doi.org/10.1093/neuonc/nou208.7
Published: 01 July 2014
